Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections.
NCT00195286 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2009-09-25
Summary
The primary objective is to study the efficacy of piperacillin/tazobactam in patients with complicated urinary tract infections
Conditions
- Urinary Infections
Interventions
- DRUG
-
piperacillin/tazobactam
Sponsors & Collaborators
-
Wyeth is now a wholly owned subsidiary of Pfizer
lead INDUSTRY
Principal Investigators
-
Medical Monitor · Wyeth is now a wholly owned subsidiary of Pfizer
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-06-30
- Primary Completion
- 2007-07-31
- Completion
- 2007-07-31
Countries
- Spain
Study Locations
More Related Trials
-
Tazocin Intervention Study
NCT00478855 ·Status: COMPLETED ·Phase: PHASE4
-
Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase
NCT00414193 ·Status: COMPLETED
-
Study Evaluation Tazocin Intervention
NCT00488189 ·Status: COMPLETED ·Phase: PHASE4
-
GSK2251052 in Complicated Urinary Tract Infection
NCT01381549 ·Status: TERMINATED ·Phase: PHASE2
-
Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)
NCT00254696 ·Status: COMPLETED ·Phase: PHASE4
-
Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection
NCT01760109 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014)
NCT02728089 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP
NCT02166476 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
NCT00195533 ·Status: COMPLETED
-
Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis
NCT00210990 ·Status: COMPLETED ·Phase: PHASE3
-
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
NCT01595438 ·Status: COMPLETED ·Phase: PHASE3
-
Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
NCT01897831 ·Status: UNKNOWN ·Phase: PHASE4
-
PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections
NCT05355350 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections
NCT00965848 ·Status: COMPLETED ·Phase: PHASE4
-
Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis
NCT00229021 ·Status: COMPLETED ·Phase: PHASE3
-
Temocillin Versus a Carbapenem as Initial Intravenous Treatment for ESBL Related Urinary Tract Infections
NCT03543436 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
NCT01763008 ·Status: COMPLETED
-
Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections
NCT03445195 ·Status: COMPLETED ·Phase: PHASE2
-
Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections
NCT05060419 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumonia
NCT01853982 ·Status: TERMINATED ·Phase: PHASE3
-
A Crossover Study to Assess the Effect of Intravenous Infusion of Piperacillin/Tazobactam on the Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) in Healthy Adult Participants
NCT03441529 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection
NCT03174795 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Efficacy of MK-7655 (Relebactam) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for Treating Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
NCT01505634 ·Status: COMPLETED ·Phase: PHASE2
-
PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)
NCT03671967 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
NCT03788967 ·Status: COMPLETED ·Phase: PHASE3